MENU
BIOA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

BioAge Labs (BIOA) Ownership - Who owns BioAge Labs?

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging... Show more

Profile

Industry
Chemicals Specialty
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
821.8M
P/E Ratio
1.68
Total Cash
285.78M
Projected Growth
N/A
Total Debt
7.13M
Revenue
5.92M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
7.97
Total Debt/Equity
53.55
Revenue/Share
0.16 USD as % of share price

Fundamentals

BIOA
Capitalization
822M
P/E Ratio
1.68
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
286M
Total Cash/Share
7.97
Total Debt
7.13M
Total Debt/Equity
53.55
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.16%
Revenue
5.92M
ROE
N/A
Book Value
277M
P/B Ratio
2.96
Cash Flow
N/A
Earnings
13.61
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
11.87
Current Revenue Per Employee
32093.75
Dividends Per Share - Security
N/A
EBITDA
-74.68M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-23.59
Shares Held By Institutions
129M
Shares Outstanding - Current
35.9M
Total Liabilities
27.6M
Total Volume MTD
N/A
Value
N/A
Gain YTD
73.243
View a ticker or compare two or three
BIOA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

a producer of sustainable chemicals

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Chemicals Specialty
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A